share_log

阿里健康：授出認股權及受限制股份單位

ALI HEALTH: GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS

Hong Kong Stock Exchange ·  Jun 14 08:36
Summary by Moomoo AI
阿里健康信息技術有限公司於2024年6月14日根據股份獎勵計劃向兩名董事授出合共3,700,700份認股權，及向576名員工授出合共73,600,600個受限制股份單位。該認股權的行使價為3.720港元，高於當日收市價3.500港元。認股權的行使期為10年，而歸屬期則根據獨立授予函件的條款而定。受限制股份單位的購買價格為零，歸屬期同樣依據授予函件的條款。此次授權旨在獎勵員工對公司的貢獻並激勵他們為公司的未來發展努力。授出的認股權及受限制股份單位均未設定表現目標。根據上市規則，此次授出的認股權及受限制股份單位已獲獨立非執行董事批准，且相關董事放棄投票權。授出後，根據股份獎勵計劃的計劃授權限額，公司仍可供未來授出超過1.2億股相關股份。
阿里健康信息技術有限公司於2024年6月14日根據股份獎勵計劃向兩名董事授出合共3,700,700份認股權，及向576名員工授出合共73,600,600個受限制股份單位。該認股權的行使價為3.720港元，高於當日收市價3.500港元。認股權的行使期為10年，而歸屬期則根據獨立授予函件的條款而定。受限制股份單位的購買價格為零，歸屬期同樣依據授予函件的條款。此次授權旨在獎勵員工對公司的貢獻並激勵他們為公司的未來發展努力。授出的認股權及受限制股份單位均未設定表現目標。根據上市規則，此次授出的認股權及受限制股份單位已獲獨立非執行董事批准，且相關董事放棄投票權。授出後，根據股份獎勵計劃的計劃授權限額，公司仍可供未來授出超過1.2億股相關股份。
On June 14, 2024, Alibaba Health Information Technology Co., Ltd. granted a total of 3,700,700 share options to two directors and 73,600,600 restricted share units to 576 employees as part of its share incentive plan. The exercise price of the share options is HKD 3.72, which is higher than the closing price of HKD 3.50 on the same day. The exercise period of the share options is 10 years, and the vesting period is determined based on the terms of the independent grant letter. The purchase price of the restricted share units is zero, and the vesting period is also based on the terms of the grant letter. The purpose of this grant is to reward employees for their contributions to the company and motivate them to work...Show More
On June 14, 2024, Alibaba Health Information Technology Co., Ltd. granted a total of 3,700,700 share options to two directors and 73,600,600 restricted share units to 576 employees as part of its share incentive plan. The exercise price of the share options is HKD 3.72, which is higher than the closing price of HKD 3.50 on the same day. The exercise period of the share options is 10 years, and the vesting period is determined based on the terms of the independent grant letter. The purchase price of the restricted share units is zero, and the vesting period is also based on the terms of the grant letter. The purpose of this grant is to reward employees for their contributions to the company and motivate them to work hard for the company's future development. There are no performance targets set for the granted share options and restricted share units. According to listing rules, the granted share options and restricted share units have been approved by independent non-executive directors, who have waived their voting rights. After the grant, the company can still grant more than 120 million related shares in the future according to the plan authorization limit of the share incentive plan.

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more